Catalysts for Erleada
15 tracked
Mar 5, 2026
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Aug 2, 2024
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Jul 9, 2024
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Dec 19, 2023
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Feb 17, 2023
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Nov 8, 2022
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Nov 8, 2022
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Apr 26, 2022
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Sep 7, 2021
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Jul 14, 2021
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Nov 20, 2020
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Sep 1, 2020
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Jul 10, 2020
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Sep 17, 2019
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Feb 14, 2018
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→